Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type (2 selected)

Type

Guidance programme

Showing 101 to 150 of 1979

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Type 1 diabetes in adultsQS208
Type 2 diabetes in adultsQS209
Asfotase alfa for treating paediatric-onset hypophosphatasiaHST23
Endoluminal gastroplication for gastro-oesophageal reflux diseaseIPG753
Percutaneous transluminal renal sympathetic denervation for resistant hypertensionIPG754
Polatuzumab vedotin in combination for untreated diffuse large B-cell lymphomaTA874
Eptinezumab for preventing migraineTA871
Cannabidiol for treating seizures caused by tuberous sclerosis complexTA873
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapiesTA872
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin geneHST22
Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myelomaTA870
Mitapivat for treating pyruvate kinase deficiency (terminated appraisal)TA867
Teclistamab for treating relapsed or refractory multiple myeloma after 3 or more therapies (terminated appraisal)TA869
Urinary tract infections in adultsQS90
Vutrisiran for treating hereditary transthyretin-related amyloidosisTA868
Antenatal careQS22
Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and managementNG231
Nivolumab with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinomaTA865
Regorafenib for previously treated metastatic colorectal cancerTA866
Transvenous obliteration for gastric varicesIPG751
Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancerIPG752
Upadacitinib for treating active non-radiographic axial spondyloarthritisTA861
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatmentsTA862
Somatrogon for treating growth disturbance in children and young people aged 3 years and overTA863
Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predictedTA864
Devices for remote monitoring of Parkinson's diseaseDG51
Maribavir for treating refractory cytomegalovirus infection after transplantTA860
Delirium: prevention, diagnosis and management in hospital and long-term careCG103
Trabeculectomy with a biodegradable collagen matrix implant for glaucomaIPG750
Tobacco: preventing uptake, promoting quitting and treating dependenceNG209
Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (terminated appraisal)TA859
Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and educationNG213
MRI-based technologies for assessing non-alcoholic fatty liver diseaseDG50
Laparoscopic insertion of a magnetic ring for gastro-oesophageal reflux diseaseIPG749
Transcutaneous electrical stimulation of the trigeminal nerve for ADHDIPG748
Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinomaTA857
Lenvatinib with pembrolizumab for untreated advanced renal cell carcinomaTA858
Diabetes in pregnancyQS109
Chronic heart failure in adultsQS9
Hip fracture: managementCG124
Hip fracture in adultsQS16
Percutaneous image-guided cryoablation of peripheral neuroma for chronic painIPG747
Mobocertinib for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapyTA855
Upadacitinib for treating moderately to severely active ulcerative colitisTA856
Thyroid cancer: assessment and managementNG230
Tobacco: treating dependenceQS207
Avatrombopag for treating primary chronic immune thrombocytopeniaTA853
Intrapartum care for healthy women and babiesCG190
Fetal monitoring in labourNG229
Cabozantinib for previously treated advanced hepatocellular carcinomaTA849

Results per page

  1. 10
  2. 25
  3. 50
  4. All